Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Three-Dimensional Craniofacial Bone Reconstruction With SmartBone on Demand.

Facciuto E, Grottoli CF, Mattarocci M, Illiano F, Compagno M, Ferracini R, Perale G.

J Craniofac Surg. 2019 May/Jun;30(3):739-741. doi: 10.1097/SCS.0000000000005277.

PMID:
30807480
2.

Concentrated adipose tissue infusion for the treatment of knee osteoarthritis: clinical and histological observations.

Roato I, Belisario DC, Compagno M, Lena A, Bistolfi A, Maccari L, Mussano F, Genova T, Godio L, Perale G, Formica M, Cambieri I, Castagnoli C, Robba T, Felli L, Ferracini R.

Int Orthop. 2019 Jan;43(1):15-23. doi: 10.1007/s00264-018-4192-4. Epub 2018 Oct 11.

PMID:
30311059
3.

Scaffolds as Structural Tools for Bone-Targeted Drug Delivery.

Ferracini R, Martínez Herreros I, Russo A, Casalini T, Rossi F, Perale G.

Pharmaceutics. 2018 Aug 8;10(3). pii: E122. doi: 10.3390/pharmaceutics10030122. Review.

4.

Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration.

Roato I, Belisario DC, Compagno M, Verderio L, Sighinolfi A, Mussano F, Genova T, Veneziano F, Pertici G, Perale G, Ferracini R.

Stem Cells Int. 2018 Apr 29;2018:4126379. doi: 10.1155/2018/4126379. eCollection 2018.

5.

Osteogenic Differentiation Modulates the Cytokine, Chemokine, and Growth Factor Profile of ASCs and SHED.

Mussano F, Genova T, Petrillo S, Roato I, Ferracini R, Munaron L.

Int J Mol Sci. 2018 May 14;19(5). pii: E1454. doi: 10.3390/ijms19051454.

6.

Does metal porosity affect metal ion release in blood and urine following total hip arthroplasty? A short term study.

Bistolfi A, Cimino A, Lee GC, Ferracini R, Maina G, Berchialla P, Massazza G, Massè A.

Hip Int. 2018 Sep;28(5):522-530. doi: 10.1177/1120700018762167. Epub 2018 May 9.

PMID:
29742937
7.

Tripled semitendinosus with single harvesting is as effective but less invasive compared to standard gracilis-semitendinosus harvesting.

Drocco L, Camazzola D, Ferracini R, Lustig S, Ravera L, Graziano E, Massè A, Bistolfi A.

Muscles Ligaments Tendons J. 2018 Apr 16;7(4):564-572. doi: 10.11138/mltj/2017.7.4.564. eCollection 2017 Oct-Dec.

8.

Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.

Roato I, Ferracini R.

Cancers (Basel). 2018 Feb 20;10(2). pii: E56. doi: 10.3390/cancers10020056. Review.

9.

Evaluation of the Effectiveness of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty: A Meta-Analysis.

Bistolfi A, Zanovello J, Ferracini R, Allisiardi F, Lioce E, Magistroni E, Berchialla P, Da Rold I, Massazza G.

Am J Phys Med Rehabil. 2018 Feb;97(2):123-130. doi: 10.1097/PHM.0000000000000847.

PMID:
29016401
10.

Adipose Derived-Mesenchymal Stem Cells Viability and Differentiating Features for Orthopaedic Reparative Applications: Banking of Adipose Tissue.

Roato I, Alotto D, Belisario DC, Casarin S, Fumagalli M, Cambieri I, Piana R, Stella M, Ferracini R, Castagnoli C.

Stem Cells Int. 2016;2016:4968724. doi: 10.1155/2016/4968724. Epub 2016 Nov 29.

11.

C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.

D'Amico L, Belisario D, Migliardi G, Grange C, Bussolati B, D'Amelio P, Perera T, Dalmasso E, Dalle Carbonare L, Godio L, Comoglio P, Trusolino L, Ferracini R, Roato I.

Oncotarget. 2016 Jul 19;7(29):45525-45537. doi: 10.18632/oncotarget.9997.

12.

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.

Castella B, Foglietta M, Sciancalepore P, Rigoni M, Coscia M, Griggio V, Vitale C, Ferracini R, Saraci E, Omedé P, Riganti C, Palumbo A, Boccadoro M, Massaia M.

Oncoimmunology. 2015 May 26;4(11):e1047580. eCollection 2015 Nov.

13.

Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.

Bertolini G, D'Amico L, Moro M, Landoni E, Perego P, Miceli R, Gatti L, Andriani F, Wong D, Caserini R, Tortoreto M, Milione M, Ferracini R, Mariani L, Pastorino U, Roato I, Sozzi G, Roz L.

Cancer Res. 2015 Sep 1;75(17):3636-49. doi: 10.1158/0008-5472.CAN-14-3781. Epub 2015 Jul 3.

14.

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.

Foglietta M, Castella B, Mariani S, Coscia M, Godio L, Ferracini R, Ruggeri M, Muccio V, Omedé P, Palumbo A, Boccadoro M, Massaia M.

Haematologica. 2014 Oct;99(10):1605-10. doi: 10.3324/haematol.2014.105866. Epub 2014 Jun 27.

15.

DKK-1 in prostate cancer diagnosis and follow up.

D'Amelio P, Roato I, Oderda M, Soria F, Zitella A, Ferracini R, Mengozzi G, Gontero P, Isaia GC.

BMC Clin Pathol. 2014 Mar 21;14(1):11. doi: 10.1186/1472-6890-14-11.

16.

CD38 and bone marrow microenvironment.

Chillemi A, Zaccarello G, Quarona V, Lazzaretti M, Martella E, Giuliani N, Ferracini R, Pistoia V, Horenstein AL, Malavasi F.

Front Biosci (Landmark Ed). 2014 Jan 1;19:152-62. Review.

PMID:
24389178
17.

Bone metastases in gastric cancer follow a RANKL-independent mechanism.

D'Amico L, Satolli MA, Mecca C, Castiglione A, Ceccarelli M, D'Amelio P, Garino M, De Giuli M, Sandrucci S, Ferracini R, Roato I.

Oncol Rep. 2013 Apr;29(4):1453-8. doi: 10.3892/or.2013.2280. Epub 2013 Feb 6.

18.

The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.

Dani N, Olivero M, Mareschi K, van Duist MM, Miretti S, Cuvertino S, Patané S, Calogero R, Ferracini R, Scotlandi K, Fagioli F, Di Renzo MF.

J Bone Miner Res. 2012 Jun;27(6):1322-34. doi: 10.1002/jbmr.1578.

19.

Iloprost modulates the immune response in systemic sclerosis.

D'Amelio P, Cristofaro MA, D'Amico L, Veneziano L, Roato I, Sassi F, Bisignano G, Saracco M, Pellerito R, Patanè S, Ferracini R, Pescarmona GP, Isaia GC.

BMC Immunol. 2010 Dec 15;11:62. doi: 10.1186/1471-2172-11-62.

20.

Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.

Roato I, Porta F, Mussa A, D'Amico L, Fiore L, Garelli D, Spada M, Ferracini R.

PLoS One. 2010 Nov 30;5(11):e14167. doi: 10.1371/journal.pone.0014167.

Supplemental Content

Loading ...
Support Center